B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 820 KRW 2.37% Market Closed
Market Cap: 117.9B KRW
Have any thoughts about
Bio-FD&C Co Ltd?
Write Note
Bio-FD&C Co Ltd
/
Balance Sheet
/
Cash Equivalents

Bio-FD&C Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bio-FD&C Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Cash Equivalents
₩11.9B
CAGR 3-Years
59%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash Equivalents
-₩440
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Cash Equivalents
₩127B
CAGR 3-Years
72%
CAGR 5-Years
95%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cash Equivalents
₩182.9B
CAGR 3-Years
61%
CAGR 5-Years
4%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash Equivalents
₩10.6B
CAGR 3-Years
-31%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash Equivalents
₩27B
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
N/A
No Stocks Found

Bio-FD&C Co Ltd
Glance View

Market Cap
117.9B KRW
Industry
Biotechnology

Bio-FD&C Co., Ltd. engages in the development of bio and health technologies. The company is headquartered in Incheon, Incheon and currently employs 61 full-time employees. The company went IPO on 2022-02-21. The firm is mainly engaged in the manufacture and sale of soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, acanthopanax koreanum adventitious root culture extract. The firm's products are mainly used as materials for cosmeceuticals, health functional foods and pharmaceuticals.

Intrinsic Value
15 556.25 KRW
Undervaluation 11%
Intrinsic Value
Price
B
What is Intrinsic Value?

See Also

What is Bio-FD&C Co Ltd's Cash Equivalents?
Cash Equivalents
11.9B KRW

Based on the financial report for Dec 31, 2023, Bio-FD&C Co Ltd's Cash Equivalents amounts to 11.9B KRW.

What is Bio-FD&C Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
40%

The average annual Cash Equivalents growth rates for Bio-FD&C Co Ltd have been 59% over the past three years , 40% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.